Form 4: Mangoceuticals CEO Jacob Cohen Receives Bonus Shares and Reports Ownership Changes

Jacob Cohen, CEO of Mangoceuticals, received 200,000 shares as a bonus and reported changes in his and The Tiger Cub Trust's beneficial ownership of the company's stock.

Summary

• Jacob Cohen, the CEO of Mangoceuticals, received 200,000 shares of common stock as a discretionary bonus for his services.
• The shares were issued under the company's Second Amended and Restated 2022 Equity Incentive Plan and are exempt under Rule 16b-3.
• Cohen also reported his direct ownership of 605,000 shares.
• Additionally, shares are held directly by The Tiger Cub Trust, for which Cohen serves as Trustee.
• Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting changes in ownership. It's neutral in tone and doesn't inherently indicate positive or negative sentiment.

Positives

• The issuance of bonus shares to the CEO could be seen as an incentive for continued performance.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• Shareholders are informed about changes in ownership by the CEO and a related trust.
• The bonus issuance may have a minor dilutive effect on existing shareholders.

Key Dates

Keywords

Mangoceuticals, Jacob Cohen, CEO, ownership, shares, bonus, Tiger Cub Trust, MGRX, Equity Incentive Plan